title: Review: the need for smoking cessation among HIV-positive smokers.
abstract: Most HIV-positive persons in the U.S. smoke cigarettes. Despite substantial clinical advances in HIV care in the era of highly active antiretroviral therapy (HAART), HIV-positive persons are at high risk of tobacco-related disease and death. HIV-positive persons have complex social, economic, psychiatric, and medical needs that may impact smoking behavior and response to smoking cessation interventions, but there is a dearth of research on smoking cessation interventions tailored to HIV-positive persons. HIV care providers should treat tobacco use with the array of evidence-based smoking cessation treatments available, updating their clinical practice as new data emerge. This article reviews the literature on the health consequences of tobacco use in HIV-positive persons, the treatment of tobacco dependence, and the research to date on smoking cessation interventions in HIV-positive persons, and it presents recommendations for future research and intervention.
authors.affiliation: Department of Medicine, Division of General Internal Medicine, Montefiore Medical Center, 111 East 210 thSt. Bronx, NY 10467, USA. snahvi@dosa.aecom.yu.edu
authors.forename: Shadi
authors.initials: S
authors.lastname: Nahvi
authors.forename: Nina A
authors.initials: NA
authors.lastname: Cooperman
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D055317:Evidence-Based Practice; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D015995:Prevalence; D011788:Quality of Life; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000150:complications* / Q000517:prevention & control
chemical_list: D019380:Anti-HIV Agents